Xortx Therapeutics Stock Performance
| XRTX Stock | USD 0.39 0.04 9.30% |
The firm maintains a market beta of 0.8, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, XORTX Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding XORTX Therapeutics is expected to be smaller as well. At this point, XORTX Therapeutics has a negative expected return of -0.65%. Please make sure to check out XORTX Therapeutics' kurtosis and the relationship between the rate of daily change and relative strength index , to decide if XORTX Therapeutics performance from the past will be repeated at some future point.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:9 | Last Split Date 2023-11-14 |
1 | Sentiment Recap How XORTX Therapeutics Inc stock performs after earnings - Weekly Trade Review Reliable Momentum Entry Alerts - B Ni V | 01/13/2026 |
2 | TipRanks - PerPlexity Initiates XORTX Therapeutics With Sell Rating, Announces Target Price 0.46 - | 02/02/2026 |
3 | Will XORTX Therapeutics Inc. outperform during market rallies - Weekly Stock Report Growth Oriented Trade Recommendations - mfd.ru | 02/10/2026 |
4 | Sectors Review Can XORTX Therapeutics Inc continue delivering strong returns - July 2025 Chart Watch Risk Controlled Stock Pick Alerts - baoquankhu1.vn | 02/20/2026 |
| Begin Period Cash Flow | 3.4 M | |
| Total Cashflows From Investing Activities | -38.9 K |
XORTX Therapeutics Relative Risk vs. Return Landscape
If you would invest 61.00 in XORTX Therapeutics on November 25, 2025 and sell it today you would lose (22.00) from holding XORTX Therapeutics or give up 36.07% of portfolio value over 90 days. XORTX Therapeutics is currently does not generate positive expected returns and assumes 4.1787% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than XORTX, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
XORTX Therapeutics Target Price Odds to finish over Current Price
The tendency of XORTX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.39 | 90 days | 0.39 | about 99.0 |
Based on a normal probability distribution, the odds of XORTX Therapeutics to move above the current price in 90 days from now is about 99.0 (This XORTX Therapeutics probability density function shows the probability of XORTX Stock to fall within a particular range of prices over 90 days) .
XORTX Therapeutics Price Density |
| Price |
Predictive Modules for XORTX Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XORTX Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of XORTX Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
XORTX Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. XORTX Therapeutics is not an exception. The market had few large corrections towards the XORTX Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold XORTX Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of XORTX Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.52 | |
β | Beta against Dow Jones | 0.80 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.13 |
XORTX Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XORTX Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XORTX Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| XORTX Therapeutics generated a negative expected return over the last 90 days | |
| XORTX Therapeutics has some characteristics of a very speculative penny stock | |
| XORTX Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (3.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| XORTX Therapeutics currently holds about 13.42 M in cash with (3.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Sectors Review Can XORTX Therapeutics Inc continue delivering strong returns - July 2025 Chart Watch Risk Controlled Stock Pick Alerts - baoquankhu1.vn |
XORTX Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of XORTX Stock often depends not only on the future outlook of the current and potential XORTX Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XORTX Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.9 M | |
| Cash And Short Term Investments | 2.5 M |
XORTX Therapeutics Fundamentals Growth
XORTX Stock prices reflect investors' perceptions of the future prospects and financial health of XORTX Therapeutics, and XORTX Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on XORTX Stock performance.
| Return On Equity | -0.95 | ||||
| Return On Asset | -0.45 | ||||
| Current Valuation | 3.2 M | ||||
| Shares Outstanding | 6.96 M | ||||
| Price To Earning | 170.67 X | ||||
| Price To Book | 2.09 X | ||||
| EBITDA | (3.71 M) | ||||
| Net Income | (3.31 M) | ||||
| Cash And Equivalents | 13.42 M | ||||
| Cash Per Share | 1.03 X | ||||
| Total Debt | 38.78 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.09 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | (3.68 M) | ||||
| Earnings Per Share | (0.40) X | ||||
| Market Capitalization | 2.72 M | ||||
| Total Asset | 4.09 M | ||||
| Retained Earnings | (21.17 M) | ||||
| Working Capital | 1.92 M | ||||
| Current Asset | 341.74 M | ||||
| Current Liabilities | 109.37 M | ||||
About XORTX Therapeutics Performance
Evaluating XORTX Therapeutics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if XORTX Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if XORTX Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (231.12) | (219.56) | |
| Return On Tangible Assets | (0.73) | (0.76) | |
| Return On Capital Employed | (1.35) | (1.28) | |
| Return On Assets | (0.69) | (0.73) | |
| Return On Equity | (0.85) | (0.89) |
Things to note about XORTX Therapeutics performance evaluation
Checking the ongoing alerts about XORTX Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for XORTX Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| XORTX Therapeutics generated a negative expected return over the last 90 days | |
| XORTX Therapeutics has some characteristics of a very speculative penny stock | |
| XORTX Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (3.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| XORTX Therapeutics currently holds about 13.42 M in cash with (3.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Sectors Review Can XORTX Therapeutics Inc continue delivering strong returns - July 2025 Chart Watch Risk Controlled Stock Pick Alerts - baoquankhu1.vn |
- Analyzing XORTX Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether XORTX Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining XORTX Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating XORTX Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of XORTX Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of XORTX Therapeutics' stock. These opinions can provide insight into XORTX Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.